CytoMed Therapeutics Limited GDTC

Healthcare — Biotechnology

0.96 0.05 5.49% as of 25 Sep

Market cap: $10.8M
P/E: 0.0×

Follow GDTC

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '24	Dec '24	Jun '25	Dec '25
ROE Full definition →	+6 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(6.84)	(8.45)	(8.47)	(9.19)
Capital Expenditures Full definition →		(0.84)	(1.51)	(1.77)	(2.22)
Other line items
Cash ROIC Full definition →		(47.68%)	(65.55%)	(80.75%)	(95.20%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.47	0.22	0.29	0.18
Capex/Depreciation Full definition →		(0.98)	(1.87)	(2.22)	(2.71)
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates